{"id":"W4403250931","doi":"10.2139/ssrn.4969633","title":"A First-in-Human Phase 1/2 Dose-Escalation Study of Mak683 (Eed Inhibitor) in Patients with Advanced Malignancies","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"De-escalation; Medicine; Maximum tolerated dose; Oncology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001089748,0.001561746,0.00216669,0.0004030248,0.0004568961,0.0009995988,0.0006655786,0.001095259,0.006386562],"category_scores_gemma":[0.0006887843,0.0006864881,0.001407758,0.0003588521,0.000758875,0.0008389509,0.0003458315,0.003708667,0.001402609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009011119,"about_ca_system_score_gemma":0.001427803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00146048,"about_ca_topic_score_gemma":0.004055056,"domain_scores_codex":[0.9997073,0.0001232441,0.000010583,0.00004798422,0.00002303257,0.00008791443],"domain_scores_gemma":[0.999599,0.000056807,0.000054743,0.00004901635,0.0000237154,0.0002166991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7166431,0.09323658,0.003778859,0.0008914084,0.001709216,0.0002762832,0.00034325,0.003794468,0.04763525,0.0004350336,0.01032572,0.1209308],"study_design_scores_gemma":[0.6187619,0.3608729,0.007881478,0.00003471339,0.0005268988,0.000255956,0.00008737114,0.001196557,0.004172393,0.0004034649,0.005765338,0.00004106454],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894133,0.00206491,0.0007605735,0.0007464006,0.0001806291,0.002179248,0.002522505,0.0001588715,0.001973613],"genre_scores_gemma":[0.977122,0.002948617,0.002975464,0.00152252,0.0001974893,0.002834514,0.004662046,0.0001079763,0.007629413],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006386562,"threshold_uncertainty_score":0.02136511,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008059983410896046,"score_gpt":0.2883609029510119,"score_spread":0.2803009195401159,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}